Pembrolizumab Solution for Infusion 25mg/mL
Prescription Only
Drug type: Therapeutic
ATC code: L01XC18
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route of administration: INTRAVENOUS
Active ingredient: Pembrolizumab
Registrant
MSD PHARMA (SINGAPORE) PTE. LTD.
Approval Date
2023-01-13
Approval Number
SIN16677P
Manufacturer
MSD International GmbH T/A MSD Ireland (Carlow)
Licence Holder
MSD PHARMA (SINGAPORE) PTE. LTD.